Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,885,902 papers from all fields of science
Search
Sign In
Create Free Account
TAL2 gene
Known as:
T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2
, T-Cell Acute Lymphocytic Leukemia 2 Gene
, bHLHa19
Expand
This gene is involved in transcriptional regulation. It plays a role in T-cell acute lymphocytic leukemia.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Homo sapiens
T Lymphoblastic Leukemia/Lymphoma
TAL2 protein, human
Transcriptional Regulation
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
RUNX1 in T-ALL: tumor suppressive or oncogenic?
T. Sanda
Blood
2017
Corpus ID: 206955694
In this issue of Blood , Choi et al demonstrated an oncogenic role of RUNX1 in T-cell acute lymphoblastic leukemia (T-ALL), 1…
Expand
2017
2017
Relapsing Pediatric T-Cell Acute Lymphoblastic Leukemia Downregulates T-Cell Properties and Upregulates Cell Adhesion
P. Richter-Pechańska
,
J. Kunz
,
+22 authors
A. Kulozik
2017
Corpus ID: 208441154
Relapse is the main cause of death from pediatric acute precursor T-cell leukemia (T-ALL), but the mechanisms underlying relapse…
Expand
Review
2014
Review
2014
Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?
A. Goldshtein
,
M. Berger
Critical reviews in oncogenesis
2014
Corpus ID: 39396736
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of thymocytes. Despite significant improvement in the…
Expand
Review
2011
Review
2011
TAL2 (T-cell acute lymphoblastic leukemia 2)
K. Vanura
2011
Corpus ID: 84564726
Review on TAL2 (T-cell acute lymphoblastic leukemia 2), with data on DNA, on the protein encoded, and where the gene is…
Expand
2010
2010
Gene expression patterns in the histopathological classification of epithelial ovarian cancer.
Honglan Zhu
,
J. Yu
Experimental and Therapeutic Medicine
2010
Corpus ID: 11278462
The purpose of this study was to screen cancer-related genes and to identify histopathological gene expression patterns as…
Expand
Highly Cited
2002
Highly Cited
2002
V(D)J-mediated Translocations in Lymphoid Neoplasms
R. Marculescu
,
T. Le
,
P. Simon
,
U. Jaeger
,
B. Nadel
Journal of Experimental Medicine
2002
Corpus ID: 15677973
Most lymphoid malignancies are initiated by specific chromosomal translocations between immunoglobulin (Ig)/T cell receptor (TCR…
Expand
Highly Cited
2001
Highly Cited
2001
J-mediated Translocations in Lymphoid Neoplasms : A Functional Assessment of Genomic Instability by Cryptic Sites
Tactggtat Agcctagatgtgtttaga
,
Tgagaaagga
,
+10 authors
Aggggtcaggccagaatg
2001
Corpus ID: 30693101
Most lymphoid malignancies are initiated by specific chromosomal translocations between immunoglobulin (Ig)/T cell receptor (TCR…
Expand
1998
1998
Cdkn 2 a , the cyclin-dependent kinase inhibitor encoding p 16 INK 4 a and p 19 ARF , is a candidate for the plasmacytoma susceptibility locus , Pctr 1
Shuling Zhang
,
E. Ramsay
,
B. Mock
1998
Corpus ID: 11532627
Plasma cell tumor induction in mice by pristane is under multigenic control. BALByc mice are susceptible to tumor development…
Expand
Highly Cited
1996
Highly Cited
1996
Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.
M. Mahajan
,
Steven T. Park
,
X. Sun
Oncogene
1996
Corpus ID: 37290700
TAL1 is a basic helix-loop-helix (bHLH) protein involved in hematopoietic development. In T cell acute lymphoblastic leukemic…
Expand
1994
1994
Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Y. Xia
,
L. Hwang
,
M. Cobb
,
R. Baer
Oncogene
1994
Corpus ID: 45852586
The TAL2 gene is activated as a result of the (7;9) (q34;q32) translocation, a chromosome defect found in the malignant cells of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE